Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies

Urology

Volumn 76, Issue 4, 2010, Pages 902-907

  Zhang, Minguang ^a   Tao, Ran ^a   Zhang, Cunming ^a   Shen, Zhoujun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; REPLANTATION; TREATMENT OUTCOME; URETER; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 77957756394     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.05.007     Document Type: Article

References (16)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 76 2008 71 96
2. H.W. Herr, D.F. Bajorin, and H.I. Scher Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome J Clin Oncol 16 1998 1298 1301
3. T. Splinter, and L. Denis Restaging procedures, criteria of response, and relationship between pathological response and survival Semin Oncol 17 1990 606 612
4. H.W. Herr Transurethral resection of muscle-invasive bladder cancer: 10-year outcome J Clin Oncol 19 2001 89 93
5. A. Zapatero, C. Martin de Vidales, and R. Arellano Updated results of bladder-sparing trimodality approach for invasive bladder cancer Urol Oncol 27 2009 1 7
6. P. Sweeney, E.D. Kursh, and M.I. Resnik Partial cystectomy Urol Clin North Am 19 1992 701 711
7. J.M. Holzbeierlein, E. Lopez-Corona, and B.H. Bochner Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection J Urol 172 2004 878 881
8. W. Kassouf, D. Swanson, M. Ashish, and Kamat Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience J Urol 175 2006 2058 2062
9. M.C. Smaldone, B.L. Jacobs, and A.M. Smaldone Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma Urology 72 2008 613 616
10. M.J. Moore, E.W. Winquist, and N. Murray Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 17 1999 2876 2881
11. M. Laufer Transurethral resection and partial cystectomy for invasive bladder cancer Semin Urol Oncol 18 2000 296 299
12. C.N. Sternberg, and M.K. Parmar Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer J Clin Oncol 19 Suppl 2001 21S 26S
13. S. Allaparthi, R. Ramanathan, and K.C. Balaji Robotic partial cystectomy for bladder cancer: a single-institutional pilot study J Endourol 24 2010 223 227
14. C.N. Sternberg, V. Pansadoro, and Calabro Fabio Can patient selection for bladder preservation be based on response to chemotherapy? Cancer 97 2003 1644 1652
15. E. Solsona, M.A. Climent, and I. Iborra Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy Eur Urol 55 2009 911 921
16. W.U. Shipley, D.S. Kaufman, and E. Zehr Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer Urology 60 2002 62 68